日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic Encoding of Pentafluorophosphato-Phenylalanine Provides PF(5)-Proteins as Phosphoprotein Mimetics

五氟磷酸苯丙氨酸的基因编码可提供 PF(5) 蛋白作为磷蛋白模拟物

Ambros, Anna Magdalena; Qianzhu, Haocheng; Tiemann, Markus; Habel, Edan; Denzinger, Katrin; Zupan, Hana; Accorsi, Matteo; Keller, Bettina G; Wolber, Gerhard; Huber, Thomas; Rademann, Jörg

International neuroblastoma risk group consortium: a model of networking for rare cancers

国际神经母细胞瘤风险组联盟:罕见癌症网络模式

Cohn, Susan L; London, Wendy B; Schleiermacher, Gudrun; Moreno, Lucas; Ambros, Inge M; Ambros, Peter F; Bagatell, Rochelle; Popovic, Maja Beck; Beiske, Klaus Hermann; Berthold, Frank; Birz, Suzi; Brisse, Hervé J; Brodeur, Garrett M; Brock, Penelope R; Burchill, Susan; Eggert, Angelika; Federico, Sara M; Fischer, Matthias; Furner, Brian T; Hero, Barbara; Machin, David; Kamijo, Takehiko; Matthay, Katherine K; Nakagawara, Akira; Naranjo, Arlene; Pötschger, Ulrike; Valteau-Couanet, Dominique; Watkins, Michael T; Irwin, Meredith S; Volchenboum, Samuel L; Park, Julie R; Pearson, Andrew D J

Detection of inflammation-related blood-brain barrier dysfunction using PET and MR imaging: a pilot study

利用PET和MR成像检测炎症相关的血脑屏障功能障碍:一项初步研究

Hilbrig, Colmar F; Baumann, Bernd; Sievert, Wolfgang; Halbgebauer, Rebecca; Huber-Lang, Markus; Beer, Ambros J; Rasche, Volker; Löffler, Jessica

Advanced neuroimaging assessment of neurodegenerative dementia syndromes: A framework for comprehensive multimodal FDG-PET, MR-perfusion, and MR-diffusion analysis

神经退行性痴呆综合征的高级神经影像学评估:综合多模态FDG-PET、MR灌注和MR扩散分析框架

Strobel, Joachim; Kassubek, Jan; Thaiss, Wolfgang; Straub-Anderl, Sarah; Uzelac, Zeljko; Jesse, Sarah; Michelberger, Laura; Solbach, Christoph; Beer, Ambros J; Beer, Meinrad; Grön, Georg; Müller, Hans-Peter; Sollmann, Nico

[(177)Lu]Lu-DOTA-TATE tumour and organ time-activity curves: prediction from a single-time-point [(68)Ga]Ga-DOTA-TATE PET/CT measurement

[(177)Lu]Lu-DOTA-TATE 肿瘤和器官时间-活性曲线:基于单次时间点 [(68)Ga]Ga-DOTA-TATE PET/CT 测量的预测

Vasić, Valentina; Gustafsson, Johan; Yousefzadeh-Nowshahr, Elham; Beer, Ambros J; Sjögreen Gleisner, Katarina; Glatting, Gerhard

Sensitive detection of minimal residual disease and immunotherapy targets by multi-modal bone marrow analysis in high-risk neuroblastoma - a multi-center study

通过多模式骨髓分析灵敏地检测高危神经母细胞瘤中的微小残留病灶和免疫治疗靶点——一项多中心研究

Gelineau, Nina U; Bozsaky, Eva; van Zogchel, Lieke M J; Rifatbegovic, Fikret; Lazic, Daria; Ziegler, Andrea; Javadi, Ahmad; Zappeij-Kannegieter, Lily; Pötschger, Ulrike; Fiocco, Marta; Ambros, Peter F; Ambros, Inge M; Bodenmiller, Bernd; van der Schoot, Ellen C; Ladenstein, Ruth; Bernkopf, Marie; Tytgat, Godelieve A M; Taschner-Mandl, Sabine

Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10.

COVID-19 治疗中的血管活性肠肽 (VIP) - 通过 ADAM10 脱落 ACE2 和 TMPRSS2

Gutzler Charlotte, Höhne Kerstin, Bani Daniele, Kayser Gian, Fähndrich Sebastian, Ambros Michael, Hug Martin J, Rieg Siegbert, Falcone Valeria, Müller-Quernheim Joachim, Zissel Gernot, Frye Björn C

Accuracy and precision analyses of single-time-point dosimetry utilising physiologically-based pharmacokinetic modelling and non-linear mixed-effects modelling

利用基于生理的药代动力学模型和非线性混合效应模型对单时间点剂量测定的准确性和精密度进行分析

Budiansah, Indra; Hardiansyah, Deni; Riana, Ade; Pawiro, Supriyanto Ardjo; Beer, Ambros J; Glatting, Gerhard

Non-linear mixed-effects modelling and population-based model selection for (131)I kinetics in benign thyroid disease

非线性混合效应模型和基于人群的模型选择用于研究良性甲状腺疾病中 (131)I 的动力学

Hardiansyah, Deni; Riana, Ade; Hänscheid, Heribert; Beer, Ambros J; Lassmann, Michael; Glatting, Gerhard

(131)I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modelling

(131)I治疗良性甲状腺疾病:基于人群模型选择的灵活单时间点剂量测定法和非线性混合效应模型

Hardiansyah, Deni; Riana, Ade; Hänscheid, Heribert; Jabar, Jaja Muhamad; Beer, Ambros J; Lassmann, Michael; Glatting, Gerhard